M160 M160 Pill - yellow & white capsule/oblong, 19mm
Pill with imprint M160 M160 is Yellow & White, Capsule/Oblong and has been identified as Didanosine Delayed Release 200 mg. It is supplied by Mylan Pharmaceuticals Inc.
Didanosine is used in the treatment of Nonoccupational Exposure; HIV Infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M160 M160
Didanosine Delayed Release
- Imprint
- M160 M160
- Strength
- 200 mg
- Color
- Yellow & White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-8887 (Discontinued)
- Inactive Ingredients
-
ferrosoferric oxide,
carboxymethylcellulose sodium,
silicon dioxide,
diethyl phthalate,
gelatin,
hypromelloses,
methacrylic acid - methyl methacrylate copolymer (1:1),
propylene glycol,
ferric oxide red,
shellac,
trisodium citrate dihydrate,
sodium lauryl sulfate,
sodium starch glycolate type A potato,
magnesium silicate,
titanium dioxide,
ferric oxide yellow,
potassium hydroxide,
ammonia
Note: Inactive ingredients may vary.
Related images for "M160 M160"
More about didanosine
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.